FDA recalls Philips CT scanner

Article

The Food and Drug Administration has recalled 15 Philips Medical Systems Tomoscan SR4000 CT scanners because of a defect that shows up when an image is reversed in the system’s databank, according to an FDA enforcement report. The defect in the

The Food and Drug Administration has recalled 15 Philips Medical Systems Tomoscan SR4000 CT scanners because of a defect that shows up when an image is reversed in the system’s databank, according to an FDA enforcement report. The defect in the system causes a patient’s image to be reversed left to right when a clinician retrieves it.

The problem was found during a routine FDA inspection several months ago, a Philips official said. He said the company hasn’t received any complaints from customers.

“There has to be a very specific set of circumstances for (the defect) to happen,” the Philips official said. “We have identified it as possible, and we are taking steps to correct the information.”

Recent Videos
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Related Content
© 2025 MJH Life Sciences

All rights reserved.